I-131 biokinetics of remnant normal thyroid tissue and residual thyroid cancer in patients with differentiated thyroid cancer: comparison between recombinant human TSH administration and thyroid hormone withdrawal

被引：0
|
作者：
Chae Moon Hong
Choon-Young Kim
Seung Hyun Son
Ji-hoon Jung
Chang-Hee Lee
Ju Hye Jeong
Shin Young Jeong
Sang-Woo Lee
Jaetae Lee
Byeong-Cheol Ahn
机构：
[1] Kyungpook National University School of Medicine/Hospital,Department of Nuclear Medicine
来源：
Annals of Nuclear Medicine | 2017年 / 31卷
关键词：
I-131; Biokinetics; TSH stimulation; Retention rate; Effective half-time; rhTSH;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：582 / 589
页数：7
相关论文
共 50 条
  • [41] COMPARISON OF 1073-MBQ AND 3700-MBQ I-131 IN POSTOPERATIVE ABLATION OF RESIDUAL THYROID-TISSUE IN PATIENTS WITH DIFFERENTIATED THYROID-CANCER
    JOHANSEN, K
    WOODHOUSE, NJY
    ODUGBESAN, O
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1991, 32 (02) : 252 - 254
  • [42] Effect of withdrawal of thyroid hormones versus administration of recombinant human thyroid-stimulating hormone on renal function in thyroid cancer patients
    An, Young-Sil
    Lee, Jeonghun
    Kim, Hyeung Kyoo
    Lee, Su Jin
    Yoon, Joon-Kee
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01):
  • [43] Effect of withdrawal of thyroid hormones versus administration of recombinant human thyroid-stimulating hormone on renal function in thyroid cancer patients
    Young-Sil An
    Jeonghun Lee
    Hyeung Kyoo Kim
    Su Jin Lee
    Joon-Kee Yoon
    [J]. Scientific Reports, 13 (1)
  • [44] Could short thyroid hormone withdrawal be an effective strategy for radioiodine remnant ablation in differentiated thyroid cancer patients?
    Piccardo, Arnoldo
    Puntoni, Matteo
    Ferrarazzo, Giulia
    Foppiani, Luca
    Bottoni, Gianluca
    Altrinetti, Vania
    Treglia, Giorgio
    Naseri, Mehrdad
    Dib, Bassam
    Cabria, Manlio
    Trimboli, Pierpaolo
    Massollo, Michela
    Giovanella, Luca
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (07) : 1218 - 1223
  • [45] Could short thyroid hormone withdrawal be an effective strategy for radioiodine remnant ablation in differentiated thyroid cancer patients?
    Arnoldo Piccardo
    Matteo Puntoni
    Giulia Ferrarazzo
    Luca Foppiani
    Gianluca Bottoni
    Vania Altrinetti
    Giorgio Treglia
    Mehrdad Naseri
    Bassam Dib
    Manlio Cabria
    Pierpaolo Trimboli
    Michela Massollo
    Luca Giovanella
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 1218 - 1223
  • [46] Recombinant thyroid-stimulating hormone in differentiated thyroid cancer
    Krausz, Y
    Uziely, B
    Nesher, R
    Chisin, R
    Glaser, B
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2001, 3 (11): : 843 - +
  • [47] Comparison of Therapeutic Efficacy and Clinical Parameters Between Recombinant Human Thyroid Stimulating Hormone and Thyroid Hormone Withdrawal in High-Dose Radioiodine Treatment with Differentiated Thyroid Cancer
    Choi S.
    Na C.J.
    Kim J.
    Han Y.-H.
    Kim H.-K.
    Jeong H.-J.
    Sohn M.-H.
    Lim S.T.
    [J]. Nuclear Medicine and Molecular Imaging, 2015, 49 (2) : 115 - 121
  • [48] Use of TSH recombinant in differentiated thyroid cancer
    Graf, Hans
    [J]. ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2007, 51 (09) : 1555 - 1556
  • [49] INTERSTITIAL I-131 ADMINISTRATION IN INOPERABLE CANCER OF THYROID
    IVANITSKAYA, VI
    NAGULIN, JA
    TSKHOVREBOV, EA
    [J]. VOPROSY ONKOLOGII, 1977, 23 (11) : 29 - 34
  • [50] Low versus High I-131 Dose for Remnant Ablation in Differentiated Thyroid Cancer
    Hackshaw, Allan
    Mallick, Ujjal
    [J]. CLINICAL MEDICINE & RESEARCH, 2009, 7 (1-2) : 1 - 1
12345